Literature DB >> 33928003

Integrated analysis and identification of nine-gene signature associated to oral squamous cell carcinoma pathogenesis.

Monika Yadav1, Dibyabhaba Pradhan2, Rana P Singh1.   

Abstract

Oral squamous cell carcinoma (OSCC) is one of the leading cancers with poor disease survival rate. Herein, we explored molecular basis, in silico identification and in vitro verification of genes associated with OSCC. Five gene expression series including, GSE30784, GSE13601, GSE9844, GSE23558 and GSE37991 were screened for differentially expressed genes (DEGs). Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were enriched by cluster Profiler. Further, protein-protein interaction network was analysed and hub genes were verified. A total of 6476 (up-regulated: 2848; down-regulated: 3628) DEGs were identified among OSCC patients and healthy controls. Gene Ontology analysis indicated DEGs enrichment in cellular motility, invasion and adhesion processes. KEGG analysis revealed enrichment of PI3K-Akt signalling, focal adhesion and regulation of actin cytoskeleton pathways. Subsequently, nine DEGs including APP, EHMT1, ACACB, PCNA, PLAU, FST, HMGA2, LAMC2 and SPP1 were correlated with TCGA expression data along with significant association towards patient's survival, recognized as hub genes. This dysregulated mRNA signature of genes was validated in two OSCC cell lines with an anti-cancer agent, fisetin. Fisetin inhibited the expression of APP, EHMT1, PCNA, PLAU, FST, HMGA2, LAMC2, SPP1 and upregulated the expression of ACACB gene which were associated with growth inhibition of both the OSCC cell lines. The regulatory effect of fisetin supported crucial role of nine hub genes identified in OSCC. This study signified that hub genes and pathways might influence the aggressiveness of OSCC. Thus, the proposed hub genes could be potential diagnostic biomarker and drug targets for OSCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13205-021-02737-4. © King Abdulaziz City for Science and Technology 2021.

Entities:  

Keywords:  Biomarkers; Cytoscape; Gene expression profiling; Hub genes; Oral squamous cell carcinoma; Survival analysis

Year:  2021        PMID: 33928003      PMCID: PMC8046867          DOI: 10.1007/s13205-021-02737-4

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


  52 in total

1.  Screening pathogenic genes in oral squamous cell carcinoma based on the mRNA expression microarray data.

Authors:  Yang Ding; Pengfei Liu; Shengsheng Zhang; Lin Tao; Jianmin Han
Journal:  Int J Mol Med       Date:  2018-02-27       Impact factor: 4.101

2.  dbGAPs: A comprehensive database of genes and genetic markers associated with psoriasis and its subtypes.

Authors:  Shweta Aggarwal; Arnab Nayek; Dibyabhaba Pradhan; Rashi Verma; Monika Yadav; Kalaiarasan Ponnusamy; Arun Kumar Jain
Journal:  Genomics       Date:  2017-10-12       Impact factor: 5.736

3.  Fisetin inhibits cellular proliferation and induces mitochondria-dependent apoptosis in human gastric cancer cells.

Authors:  Akash Sabarwal; Rajesh Agarwal; Rana P Singh
Journal:  Mol Carcinog       Date:  2016-06-21       Impact factor: 4.784

4.  IL-1β promotes malignant transformation and tumor aggressiveness in oral cancer.

Authors:  Chia-Huei Lee; Jeffrey Shu-Ming Chang; Shih-Han Syu; Thian-Sze Wong; Jimmy Yu-Wai Chan; Ya-Chu Tang; Zhi-Ping Yang; Wen-Chan Yang; Chiung-Tong Chen; Shao-Chun Lu; Pei-Hua Tang; Tzu-Ching Yang; Pei-Yi Chu; Jenn-Ren Hsiao; Ko-Jiunn Liu
Journal:  J Cell Physiol       Date:  2015-04       Impact factor: 6.384

5.  UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.

Authors:  Darshan S Chandrashekar; Bhuwan Bashel; Sai Akshaya Hodigere Balasubramanya; Chad J Creighton; Israel Ponce-Rodriguez; Balabhadrapatruni V S K Chakravarthi; Sooryanarayana Varambally
Journal:  Neoplasia       Date:  2017-07-18       Impact factor: 5.715

6.  HMGA2 enhances 5-fluorouracil chemoresistance in colorectal cancer via the Dvl2/Wnt pathway.

Authors:  Xi Xu; Yunfeng Wang; Hong Deng; Chungang Liu; Jingjing Wu; Maode Lai
Journal:  Oncotarget       Date:  2018-01-10

7.  The prognostic value of proliferating cell nuclear antigen expression in colorectal cancer: A meta-analysis.

Authors:  He Zhou; Tao Huang; Yongfu Xiong; Linglong Peng; Rong Wang; Guang Jun Zhang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

8.  Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry.

Authors:  Jiao Yuan; Kevin H Kensler; Zhongyi Hu; Youyou Zhang; Tianli Zhang; Junjie Jiang; Mu Xu; Yutian Pan; Meixiao Long; Kathleen T Montone; Janos L Tanyi; Yi Fan; Rugang Zhang; Xiaowen Hu; Timothy R Rebbeck; Lin Zhang
Journal:  PLoS Genet       Date:  2020-02-14       Impact factor: 5.917

9.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks.

Authors:  Gabriela Bindea; Bernhard Mlecnik; Hubert Hackl; Pornpimol Charoentong; Marie Tosolini; Amos Kirilovsky; Wolf-Herman Fridman; Franck Pagès; Zlatko Trajanoski; Jérôme Galon
Journal:  Bioinformatics       Date:  2009-02-23       Impact factor: 6.937

10.  Crosstalk between Fisetin-induced Apoptosis and Autophagy in Human Oral Squamous Cell Carcinoma.

Authors:  Bong-Soo Park; Nak-Eun Choi; Ji Hye Lee; Hae-Mi Kang; Su-Bin Yu; Hye-Jin Kim; Hyun-Kyung Kang; In-Ryoung Kim
Journal:  J Cancer       Date:  2019-01-01       Impact factor: 4.207

View more
  2 in total

Review 1.  In silico Methods for Identification of Potential Therapeutic Targets.

Authors:  Xuting Zhang; Fengxu Wu; Nan Yang; Xiaohui Zhan; Jianbo Liao; Shangkang Mai; Zunnan Huang
Journal:  Interdiscip Sci       Date:  2021-11-26       Impact factor: 3.492

2.  PKMYT1 regulates the proliferation and epithelial-mesenchymal transition of oral squamous cell carcinoma cells by targeting CCNA2.

Authors:  Ye Cai; Weidong Yang
Journal:  Oncol Lett       Date:  2021-12-27       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.